Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Magyar Onkologia|March 14, 2024
[Electromagnetic procedures in the treatment of pancreatic cancer: eminent or resentful?]Magdolna Dank, Magdolna Herold, Márton Tamás Garay, et al.
Orvosi Hetilap|January 6, 2012
[Modern pharmacological therapy of breast cancer]István Láng, Zsuzsanna Kahán, Erika Hitre, et al.
Patient Education and Counseling|March 10, 2015
Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?Tímea Tőkés, László Torgyík, Gyöngyvér Szentmártoni, et al.
Magyar Onkologia|March 21, 2025
[Physical therapy of cancer patients - narrative review and expert opinion]Tamás Bender, Éva Szekanecz, Izabella Gomez, et al.
British Journal of Cancer|July 14, 2018
Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancerPhilip E Lammers, Magdolna Dank, Riccardo Masetti, et al.
Journal of Clinical Medicine|July 15, 2026
Vertebral Fractures Beyond Bone Density in Breast Cancer: A Real-World Study of Endocrine Therapy and FRAX ReclassificationRéka Kollár, Tamás Leel-Őssy, Eszter Szigeti, et al.
World Journal of Clinical Cases|June 6, 2022
High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancerZoltan Herold, Magdolna Herold, Gyorgy Herczeg, et al.
Breast Cancer Research and Treatment|July 10, 2013
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancerZsuzsanna Mihály, Máté Kormos, András Lánczky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2026
Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancerTamás Szekeres, Máté Ádám Balázs, Bálint Madarász, et al.
Orvosi Hetilap|March 24, 2020
[Attachment style, relationship and sexual satisfaction: comparing breast cancer patients and healthy women]Judit Désfalvi, Csilla Lakatos, Sára Imola Csuka, et al.
Pageof 12